v3.25.2
Condensed Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 944,919 $ 25,092
Due from sponsor 28,601
Total current assets 973,520 25,092
Deferred offering costs associated with proposed public offering 170,797
Cash held in Trust Account 253,187,419
Prepaid insurance 171,188  
Total Assets 254,332,127 195,889
Current liabilities:    
Accrued offering expenses 170,797
Accrued expenses and accounts payable 25,500 55,240
Total current liabilities 25,500 226,037
Deferred underwriting commission 12,045,000
Total liabilities 12,070,500 226,037
Commitments and Contingencies    
Class A ordinary shares, $0.0001 par value; 25,300,000 and -0- shares subject to possible redemption at $10.01 per share at June 30, 2025 and December 31, 2024 respectively 253,187,419
Shareholder’s Deficit (Equity)    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of June 30, 2025 and December 31, 2024
Additional paid-in capital 24,367
Accumulated deficit (10,926,425) (55,148)
Total shareholder’s deficit (10,925,792) (30,148)
Total Liabilities and Shareholder’s (Deficit) Equity 254,332,127 195,889
Class A Ordinary Shares [Member]    
Shareholder’s Deficit (Equity)    
Common stock, value issued
Class B Ordinary Shares [Member]    
Shareholder’s Deficit (Equity)    
Common stock, value issued [1] $ 633 $ 633
[1] The number of shares outstanding as of December 31, 2024 included up to 825,000 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (see Notes 6 and 8).